Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer
ConclusionAdjuvant chemotherapy with S-1 is feasible treatment in patients with resected biliary tract cancer. It is necessary to conduct a phase III study to confirm the efficacy of adjuvant therapy of S-1 in patients with resected BTC.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Bile | Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Gallbladder Cancer | Study | Toxicology